Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Artiva Biotherapeutics, Inc. (ARTV) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-21.53M |
|
-- |
|
-- |
|
$22.90M |
|
$-22.90M |
|
$1.37M |
|
$-21.53M |
|
$-21.53M |
|
$-21.53M |
|
$-21.53M |
|
$-21.53M |
|
$-21.53M |
|
$-22.90M |
|
$-22.23M |
|
24.48M |
|
24.48M |
|
$-0.88 |
|
$-0.88 |
|
| Balance Sheet Financials | |
$129.52M |
|
$6.98M |
|
$19.34M |
|
$148.86M |
|
$11.12M |
|
-- |
|
$8.52M |
|
$19.64M |
|
$129.22M |
|
$129.22M |
|
$129.22M |
|
24.55M |
|
| Cash Flow Statement Financials | |
$-62.02M |
|
$47.37M |
|
$0.13M |
|
$40.49M |
|
$25.97M |
|
$-14.52M |
|
$5.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.65 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-64.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.66% |
|
-16.66% |
|
-14.46% |
|
-16.66% |
|
$5.26 |
|
$-2.62 |
|
$-2.53 |
|